All Approved Indications of Five Akeso's Innovative Drugs Included in China's Latest NRDL: Featuring Two First-in-Class Bispecifics with New First-Line Indications and Three Newly Negotiated Drugs

HONG KONG, Dec. 7, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) announced the successful inclusion of all five of the Company’s self-developed innovative drugs into the updated National Reimbursement Drug List (NRDL) for 2025, released by China’s…

More retail announced for Concourse E at Dulles International

Construction on the new Concourse E at Dulles International Airport is well underway with a target opening of late 2026. The post More retail announced for Concourse E at Dulles International first appeared on The Burn.